抗VEGF联合激光治疗重度非增殖期糖尿病视网膜病变对黄斑区血流密度的影响
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

广西壮族自治区科技厅科技攻关项目(No.1598012-17); 广西医疗卫生适宜技术开发与推广应用项目(No.S2020074); 广西壮族自治区卫生健康委员会自筹经费科研课题(No.Z20200457)


Effect of anti-VEGF combined with laser therapy on macular blood flow density in patients with severe non-proliferative diabetic retinopathy
Author:
Affiliation:

Fund Project:

Key Technologies R & D Program of Guangxi Zhuang Autonomous Region(No.1598012-17); Guangxi Medical and Hygienic Appropriate Technology Development and Promotion Application Project(No.S2020074); Sanitary and Health Commission of Guangxi Zhuang Autonomous Region Self-funded Scientific Research Project(No.Z20200457)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨抗血管内皮生长因子(VEGF)联合全视网膜光凝术(PRP)治疗重度非增殖期糖尿病视网膜病变(sNPDR)合并黄斑水肿(DME)对黄斑区血流密度变化的影响。

    方法:回顾性选取2018-10/2019-04在我院确诊的sNPDR合并DME患者30例30眼,根据治疗方案进行分组,其中A组15例15眼采用“1+PRN”方案采用玻璃体腔内注射雷珠单抗7d后行PRP治疗,B组15例15眼采用单纯PRP治疗。对比两组治疗前后黄斑区6mm×6mm浅层毛细血管(SCP)和深层毛细血管(DCP)血流密度、黄斑中心凹厚度(CMT)、最佳矫正视力(BCVA)变化情况。

    结果:与术前相比,A组患者术后2wk,1mo DCP血流密度显著增加、CMT明显降低、BCVA明显改善(均P<0.05),B组患者术后1mo CMT降低、BCVA改善(均P<0.05)。术后2wk、1mo,A组患者DCP血流密度较B组明显增加(43.37%±2.72% vs 41.03%±2.60%,45.01%±2.28% vs 41.20%±2.43%,均P<0.05),CMT较B组明显降低(303.4±30.36μm vs 329.60±31.47μm,268.67±30.27μm vs 319.40±28.63μm,均P<0.05),BCVA(LogMAR)较B组明显改善(0.28±0.11 vs 0.40±0.13,0.23±0.14 vs 0.38±0.15,均P<0.05)。

    结论:抗VEGF联合PRP治疗sNPDR合并DME患者短期内可有效增加DCP血流密度,减轻黄斑水肿,改善视力。

    Abstract:

    AIM:To investigate the effect of anti-VEGF combined with panretinal photocoagulation(PRP)in the treatment of severe non-proliferative diabetic retinopathy(sNPDR)with diabetic macular edema(DME)on the change of macular blood flow density.

    METHODS: Data of 30 eyes in 30 patients at Guangxi Zhuang Autonomous Region People's Hospital from October 2018 to April 2019 were retrospectively reviewed, and they were randomly divided into group A and group B each with 15 cases. Group A was received PRP treatment after one initial intravitreal ranibizumab injection followed by pro re nata(PRN)at 7d, while group B was administered PRP alone. The blood flow density of superficial capillary plexus(SCP)and deep capillary plexus(DCP)in macular area(6mm×6mm), central macular thickness(CMT), and best corrected visual acuity \〖BCVA(LogMAR)\〗 were compared between the two groups before and after treatment.

    RESULTS: Compared with before operation, the DCP blood flow density was significantly increased, CMT was obviously decreased, and BCVA was markedly improved in group A at 2wk and 1mo after surgery(all P<0.05), while CMT was decreased and BCVA was improved in group B at 1mo after operation(all P<0.05). Postoperative in group A at 2wk and 1mo, the DCP blood flow density was significantly higher than that in group B(43.37%±2.72% vs 41.03%±2.60%, 45.01%±2.28% vs 41.20%±2.43%, P<0.05), CMT was obviously lower than group B(303.4±30.36μm vs 329.60±31.47μm, 268.67±30.27μm vs 319.40±28.63μm, all P<0.05), and BCVA(LogMAR)was markedly improved compared with group B(0.28±0.11 vs 0.40±0.13, 0.23±0.14 vs 0.38±0.15, all P<0.05).

    CONCLUSION: Anti-VEGF combined with PRP can effectively increase DCP blood flow density, reduce macular edema and improve visual acuity in the short term in patients with sNPDR with DME.

    参考文献
    相似文献
    引证文献
引用本文

黄孔乾,沈朝兰,唐芬,等.抗VEGF联合激光治疗重度非增殖期糖尿病视网膜病变对黄斑区血流密度的影响.国际眼科杂志, 2021,21(9):1627-1631.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-03-11
  • 最后修改日期:2021-08-09
  • 录用日期:
  • 在线发布日期: 2021-08-18
  • 出版日期: